Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP
BPH With Urinary Obstruction, BPH, Hematuria
About this trial
This is an interventional treatment trial for BPH With Urinary Obstruction
Eligibility Criteria
Inclusion Criteria: Males 18 -89 undergoing HoLEP Willing to sign the Informed Consent Form Able to read, understand, and complete patient questionnaires. Exclusion Criteria: Allergy or hypersensitivity to furosemide or other loop diuretic Anuric patients or patients with liver failure Patients having a concurrent ureteroscopy +/- laser lithotripsy, percutaneous nephrolithotomy, or non-urologic surgery at the time of their HoLEP Anticipated need for perineal urethrostomy at the time of HoLEP Patient not undergoing catheter removal and voiding trial at Northwestern Memorial Hospital
Sites / Locations
- Northwestern UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Loop Diuretic (Furosemide)
Control
This group of patients will receive 20mg of IV furosemide during the morcellation phase of their HoLEP.
This group of patients will not receive 20mg of IV furosemide during the morcellation phase of their HoLEP.